Home » AstraZeneca, because Denmark, Norway and Iceland have suspended the vaccine

AstraZeneca, because Denmark, Norway and Iceland have suspended the vaccine

by admin

ServiceThe case

Precautionary stop after a few blood clots. Investigations on three victims in Italy, withdrawn a lot. Draghi hears von der Leyen: “No link with thrombosis”

by Francesca Cerati

Covid vaccine, Denmark suspends AstraZeneca. Aifa blocks lot

Precautionary stop after a few blood clots. Investigations on three victims in Italy, withdrawn a lot. Draghi hears von der Leyen: “No link with thrombosis”

4 ‘of reading

The good news of the approval of Johnson & Johnson’s single-dose vaccine by EMA, which thus expands the number of doses for the vaccination campaign, has been partly overshadowed by the temporary stop put in place by Denmark (and then also by Iceland and Norway) of the AstraZeneca vaccine. Although the suspension will only last 14 days and is described as a precautionary measure, the news has triggered a domino effect in other countries as well. Italy included.

The reasons for the Danish choice

The decision taken by the Danish Health Authority “follows the news of serious cases of blood clot formation, at the basis of thrombosis and embolisms, in people vaccinated with the AstraZeneca vaccine“, the body explained in a statement, adding however that “at present it has not been determined that there is a link between the vaccine and these clinical manifestations and there is good evidence that the vaccine is safe and effective.” In Denmark, according to data from the state Serum institut, more than 142,000 people have received a first injection of the AstraZeneca vaccine. On Sunday, Austria also suspended the administration of a batch of AstraZeneca vaccines (number ABV5300) following the death of one woman from multiple thrombosis and the hospitalization of another for pulmonary embolism after the administration of two doses of the vaccine. Following these episodes, Estonia, Lithuania, Luxembourg and Latvia also suspended the use of vaccines from the same batch, which has one million doses and was distributed in 17 countries, as a precaution.

See also  War Ukraine Russia, news. Zelensky in Europe, meeting with Mattarella tomorrow. LIVE

Loading…

Aifa suspends lot ABV2856

Even if Italy is not among these, Aifa has nevertheless decided to suspend as a precaution another AstraZeneca batch, ABV2856, regarding the “reporting of some serious adverse events, in temporal concomitance with the administration of doses belonging to to this lot, even if at the moment no causal link between the vaccine and these events has been established “, explains Aifa. In the evening, the dg Nicola Magrini specified that there are three cases. Two investigations were opened by the Syracuse and Catania prosecutors, after the suspicious deaths of a policeman and a soldier immediately after the administration of the first dose of the AstraZeneca vaccine, the batch of which was seized by decision of the judiciary.

AstraZeneca’s position

The company that produces the vaccine is “collaborating with health and regulatory authorities” and states that “from an analysis of our data on over 10 million administrations, no evidence of an increased risk of pulmonary embolism or venous thrombosis emerged. deep in any age group, sex, batch or in any country where AstraZeneca vaccine against Covid-19 was used. The number of these events is significantly lower in vaccinated subjects than the number observed in the general population ». Furthermore, AstraZeneca specifies, “from the quality checks carried out internally, no aspects were highlighted that could have had an impact on the quality, safety, efficacy of the batch in question and the competent authorities were promptly informed of this”.

Ema: there is no correlation

Ema said there is no evidence linking AstraZeneca to the two Austrian cases, adding that in Europe the number of people reporting blood clots after injection was no higher than in the general population: 22 out of 3 cases. million (as of March 9). However, it has already initiated a further accelerated review of the AstraZeneca vaccine. Prime Minister Mario Draghi and the President of the EU Commission Ursula Von der Leyen, during a telephone conversation, announced the palace to reiterate that there is no evidence of a link between the cases of thrombosis recorded in Europe and the administration of this vaccine. Chigi.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy